title: Staphylococcus cohnii septicaemia in a patient with colon cancer.
abstract: A coagulase-negative staphylococcal strain was isolated from peripheral blood and central venous catheter blood of a febrile patient with cancer. This isolate, initially classified by a commercial test as Staphylococcus kloosii, was definitively assigned to Staphylococcus cohnii by physiological and molecular tests. The strain lacked virulence factors, such as biofilm production and haemagglutination, and was sensitive to the antibiotics tested. The data suggest that rare micro-organisms with low pathogenic potential can cause severe illness in cancer patients; reference identification is required, however, to describe correctly the epidemiological characteristics and virulence factors of these clinical isolates.
authors.affiliation: Microbiologia, Immunologia e Virologia1 and Oncologia Medica B2, Centro di Riferimento Oncologico, Aviano, Italy.
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Basaglia
authors.affiliation: Microbiologia, Immunologia e Virologia1 and Oncologia Medica B2, Centro di Riferimento Oncologico, Aviano, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Moras
authors.affiliation: Microbiologia, Immunologia e Virologia1 and Oncologia Medica B2, Centro di Riferimento Oncologico, Aviano, Italy.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Bearz
authors.affiliation: Microbiologia, Immunologia e Virologia1 and Oncologia Medica B2, Centro di Riferimento Oncologico, Aviano, Italy.
authors.forename: Simona
authors.initials: S
authors.lastname: Scalone
authors.affiliation: Microbiologia, Immunologia e Virologia1 and Oncologia Medica B2, Centro di Riferimento Oncologico, Aviano, Italy.
authors.forename: Paolo De
authors.initials: P
authors.lastname: Paoli
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000150:complications* / Q000382:microbiology*; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D018805:Sepsis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology*; D013210:Staphylococcus / Q000145:classification* / Q000302:isolation & purification* / Q000472:pathogenicity; D037521:Virulence Factors / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D037521:Virulence Factors; D002442:Ceftazidime